Therefore, treatments targeting abnormal glucose metabolism, insulin resistance, and IGF-1/IGF-1R signaling axis may exert potential therapeutic effects to decrease the tumor burden and the metastasis risks of intraocular malignancies. Here, IGF1R is linked to neoplasm.